INTRODUCTION {#sec1-1}
============

Rotavirus is the most common cause of severe diarrhea in children, resulting in the hospitalization of approximately 55,000 children each year in the United States.\[[@ref1][@ref2]\] In the developing world rotavirus may account for 1 million childhood deaths as well as significant morbidity each year.\[[@ref3]\]

Rotavirus is a non-enveloped double-stranded RNA virus.\[[@ref4]--[@ref7]\] The incubation period for rotavirus disease is approximately 2 days. The disease is characterized by vomiting and watery diarrhea for 3-8 days, with fever and abdominal pain occurring frequently. Rotaviruses are the leading cause of severe dehydrating diarrhea in infants and young children and some adult diarrheal disease.\[[@ref8]--[@ref11]\] Infection results in life-long protection from the acute disease although subclinical infections may occur and protection wane in the elderly.

There are three rotavirus groups, A, B and C, which are both antigenically and genetically distinct. The inner capsid protein, VP6 is the common or group-specific antigen. Group A rotaviruses are the predominant cause of rotavirus disease throughout the world. More than 95% of all children have been infected by group A rotaviruses by the age of 4 and in developing countries infection occurs primarily between 4 months and 2 years of age. \[[@ref6]\] Group A rotaviruses can be subtyped by monoclonal antibodies based on VP6-specific antibodies. There are 10 rotavirus serotypes at this point, but only serotypes 1-4 are epidemiologically important for human disease throughout the world.\[[@ref9]--[@ref10]\] All human subgroup I rotaviruses are serotype 2. Subgroup II rotaviruses are serotypes 1, 3 and 4.\[[@ref9]\]

Currently, there is no published data on the prevalence of subgroups and serotypes of rotavirus in the Eastern province of Saudi Arabia. The aim of the present study was to assess the rotavirus infection in children with acute gastroenteritis, and to identify the subgroups and serotypes of rotavirus in the Children and Maternity Hospital in Dammam, Eastern Saudi Arabia.

MATERIALS AND METHODS {#sec1-2}
=====================

Study population and period of study {#sec2-1}
------------------------------------

All children under 5 years of age with gastroenteritis attending the emergency rooms and in the pediatric wards of the Children and Maternity Hospital in Dammam were included in the study (N=156). The period of the study was 1 year (2007-2008).

Techniques used for data collection {#sec2-2}
-----------------------------------

Stool specimens (N=156) were collected from the subjects by the conventional techniques. Samples were transported in buffered media. The initial laboratory diagnosis of rotavirus shedding was established using the novel Rotavirus STAT-PAK immunochromatographic test (Chembio diagnostic systems Inc., Medford, NY).

Subgroup and G-serotype of the positive stool specimens were analyzed by the ELISA method, using monoclonal antibodies specific for G-serotypes 1, 2, 3 and 4, and subgroups I and II, which were produced in Sapporo, Japan.\[[@ref12]--[@ref14]\] The ELISA used in the present study has been described previously.

RESULTS {#sec1-3}
=======

A total of 156 stool specimens were collected from the children with diarrhea. The mean age of patients was 2.4 years of age, 69 of whom were males and 87 females. The average duration of illness was 2 days.

Using the novel immmunochromatographical assay, 37 samples were shown to be positive for rotavirus (23.7%). There was no significantly different seasonal variation in prevalence of rotavirus in our study. The causative organisms for diarrhea in the rest of the samples were mainly Gram-negative bacteria (*Escherichia coli, Salmonella spp., Shigella spp., Campylobacter spp*., etc).

Of the 37 rotavirus-positive specimens serotyped with an ELISA, five (13.5%) were found to be serotype 1 (subgroup II), 4 (10.8%) were serotype 3 (subgroup II), four were serotype 4 (10.8%) (subgroup II), two (5.4%) were serotype 2 (subgroup I) and eight (21.6%) were mixed (recognized by both serotype 1- and serotype 4-specific monoclonal antibodies). Hence, subgroup I was found to constitute 5.4% of the isolates and subgroup II constituted 56.7% of the isolates. The remaining 14 specimens (37.8%) were non-typeable with the monoclonal antibodies used in the present study.

DISCUSSION {#sec1-4}
==========

Rotavirus is a major cause of diarrhea in children. A live-attenuated vaccine against rotavirus infection (Rotarix and RotaTeq) was recently approved by the FDA and CDC. Identification of the infection rate by rotavirus and the subgroups and serotypes of rotavirus will help to assess the efficacy of the vaccine.

Electron microscopy, ELISA, RNA electrophoresis, nucleic acid hybridization, PCR and direct cultivation have all been used to diagnose rotaviruses in clinical samples. However, diagnosis by rapid antigen detection of rotavirus in stool specimens is widely used.\[[@ref15]\]

In this study, a novel immunochromatographical method was used. The advantage of this technique is that it is sensitive, specific, fast and can be applied as a point-of-care test. However, commercial immunoassays for rotaviruses detect only Group A rotaviruses since they are the most common cause of severe watery diarrhea in infancy and early childhood.\[[@ref2]\]

The prevalence of rotavirus infection has been reported in some regions of Saudi Arabia\[[@ref16]--[@ref25]\] \[[Table 1](#T1){ref-type="table"}\]. El-Sheikh *et al*\[[@ref16]\] assessed the prevalence of viral, bacterial and parasitic pathogens in children in Jeddah, Saudi Arabia. Rotavirus was detected in 34.6% of the specimens of the hospitalized patients and in 5.9% of the specimens of the outpatients. In the Milaat *et al*\[[@ref19]\] analysis of the causative agents of diarrheal diseases in two referral hospitals in Jeddah, Saudi Arabia, 41.3% of the cases were found to be due to rotavirus (RVGE) while 53.1% cases showed no causative pathogens. In the Al-Freihi *et al*\[[@ref23]\] prospective study of acute diarrheal diseases in the Eastern Province of Saudi Arabia, rotaviruses were responsible for only 11.5% of the cases of diarrheal diseases in children. None of the above studies used the immunochromatographical assay used this study.
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The El-Assouli *et al*\[[@ref17]\] report of the subgroups, serotypes of rotavirus-positive stool specimens in Jeddah, Saudi Arabia indicated that 14.3% were of subgroup 1, 82.1% were of subgroup II and 3.6% were a mixture of subgroup I and II. All subgroup I were of serotype 2 and all subgroup II were of serotype 1, 3 or 4. In the current study, 5.4% of rotavirus isolates were found to be subgroup I (serotype 2), 56.7% were subgroup II (serotypes 1, 3 and 4) and 21.6% were a mixture of subgroup I and II. In addition, 37.1% of the rotavirus isolates were non-typeable. The differences in the serotypes between the two studies could be explained by the differences in the monoclonal antibodies used. Alternatively, these differences could be due to different serotypes circulating in these localities.

The success rate of serotyping of rotavirus in stools with monoclonal antibodies in an ELISA system has been extremely variable, ranging from 100% in Sweden to only 29% in Bangladesh.\[[@ref13]\] Likewise, 75-90% of rotavirus-positive specimens from inpatients at Royal Children\'s Hospital in Victoria, Australia, were typeable, compared to only 40-50% of specimens from overseas sources (mainly Indonesia).\[[@ref14]\] Inability to type 37.1% of the rotavirus-positive specimens in the present study, may be due to the absence of epitopes recognizable by the particular monoclonal antibodies used because of strain variations or the presence of inhibitory factors in stools.\[[@ref12]\] On the other hand, coinfection with two serotypes may explain mixed infections.

A survey of serotypes of rotavirus in the whole region as well as in the whole of Saudi Arabia will provide important information about the subgroups and serotypes of rotavirus in the community and may help to determine the subgroups and subtypes that should be included in the rotavirus vaccine to be used in Saudi Arabia.
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